Abuse Liability of Medications Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD)

REFERENCES

• Faraone SV, Biederman J, Roe C. Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis. J Clin Psychopharmacol. 2002;5:468–473.
   Google Scholar
• Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2004;24:24–29.
   PubMed Web of Science ®Google Scholar
• Greenhill LL, Halperin JM, Abikoff H. Stimulant medications. J Am Acad Child Adolesc Psychiatry. 1999;38:503–512.
   PubMed Web of Science ®Google Scholar
• Biederman J, Wilens T, Mick E, , et al Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1997;36:21–29.
   PubMed Web of Science ®Google Scholar
• Robinson TE, Becker JB. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 1986;396:157–198.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Insel TR. What are the long-term effects of methylphenidate treatment? Biol Psychiatry. 2003;54:1307–1309.
   PubMed Web of Science ®Google Scholar
• Andersen SL, Arvanitogiannis A, Pliakas AM, LeBlanc C, Carlezon WA, Jr. Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci. 2002;5:13–14.
   PubMed Web of Science ®Google Scholar
• Carlezon WA, Jr., Mague SD, Andersen SL. Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry. 2003;54:1330–1337.
   PubMed Web of Science ®Google Scholar
• Brandon CL, Marinelli M, Baker LK, White FJ. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology. 2001;25:651–661.
   PubMed Web of Science ®Google Scholar
• Brandon CL, Marinelli M, White FJ. Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons. Biol Psychiatry. 2003;54:1338–1344.
   PubMed Web of Science ®Google Scholar
• Schenk S, Izenwasser S. Pretreatment with methylphenidate sensitizes rats to the reinforcing effects of cocaine. Pharmacol Biochem Behav. 2002;72:651–657.
   PubMed Web of Science ®Google Scholar
• Moll GH, Hause S, Ruther E, Rothenberger A, Huether G. Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. J Child Adolesc Psychopharmacol. 2001;11:15–24.
   PubMed Web of Science ®Google Scholar
• Strakowski SM, Sax KW, Setters MJ, Keck PE, Jr. Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Biol Psychiatry. 1996;40:872–880.
   PubMed Web of Science ®Google Scholar
• Wachtel SR, de Wit H. Subjective and behavioral effects of repeated d-amphetamine in humans. Behav Pharmacol. 1999;10:271–281.
   PubMedGoogle Scholar
• Volkow ND, Wang GJ, Fowler JS, , et al Differences in regional brain metabolic responses between single and repeated doses of methylphenidate. Psychiatry Res. 1998;83:29–36.
   PubMed Web of Science ®Google Scholar
• Lambert NM, Hartsough CS. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil. 1998;31:533–544.
   PubMed Web of Science ®Google Scholar
• Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 1999;104:20.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003;111:179–185.
   PubMed Web of Science ®Google Scholar
• Balster RL, Bigelow GE. Guidelines and methodological reviews concerning drug abuse liability assessment. Drug Alcohol Depend. 2003;70(3 Suppl.):S13–S40.
   Google Scholar
• Glennon RA, Jarbe TUC, Frankenheim J. Drug Discrimination: Applications to Drug Abuse Research. Rockville, Md.: US Department of Health and Human Services; 1991.
   Google Scholar
• Glennon RA, Young R. The study of structure activity relationships using drug discrimination methodology. In: Bozarth MA, ed. Methods of Assessing the Reinforcing Properties of Abused Drugs. New York: Springer-Verlag;1987:373–390.
   Google Scholar
• Preston KL, Bigelow GE. Subjective and discriminative effects of drugs. Behav Pharmacol. 1991;2:293–313.
   PubMed Web of Science ®Google Scholar
• de la Garza R, Johanson CE. Discriminative stimulus properties of intragastrically administered d-amphetamine and pentobarbital in rhesus monkeys. J Pharmacol Exp Ther. 1987;243:955–962.
   PubMedGoogle Scholar
• Evans SM, Johanson CE. Amphetamine-like effects of anorectics and related compounds in pigeons. J Pharmacol Exp Ther. 1987;241:817–825.
   Google Scholar
• Heishman SJ, Henningfield JE. Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans. Psychopharmacology (Berl). 1991;103:436–442.
   PubMedGoogle Scholar
• Rush CR, Kollins SH, Pazzaglia PJ. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans. Exp Clin Psychopharmacol. 1998;6:32–44.
   PubMed Web of Science ®Google Scholar
• Rush CR, Baker RW. Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers. Exp Clin Psychopharmacol. 2001;9:59–73.
   PubMed Web of Science ®Google Scholar
• Jaffe JH, Jaffe SK. Historical perspectives on the use of subjective effects measures in assessing the abuse potential of drugs. In: Fishman MW, Mello NK, eds. Testing for Abuse Liability of Drugs in Humans. National Institute on Drug Abuse Monograph No 92, Department of Health and Human Services Publication No (ADM)89–1613. Washington, DC: US Government Printing Office;1989:43–72.
   Google Scholar
• Martin WR, Sloan JW, Sapira JD, Jasinski DR. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther. 1971;12:245–258.
   PubMed Web of Science ®Google Scholar
• Smith RC, Davis JM. Comparative effects of d-amphetamine, l-amphetamine, and methylphenidate on mood in man. Psychopharmacology (Berl). 1977;53:1–12.
   PubMed Web of Science ®Google Scholar
• Fredericks EM, Kollins SH. Assessing methylphenidate preference in ADHD patients using a choice procedure. Psychopharmacology (Berl). 2004;175:391–398.
   PubMed Web of Science ®Google Scholar
• Kollins SH, Shapiro SK, Newland MC, Abramowitz A. Discriminative and participant-rated effects of methylphenidate in children diagnosed with attention deficit hyperactivity disorder (ADHD). Exp Clin Psychopharmacol. 1998;6:375–389.
   PubMed Web of Science ®Google Scholar
• MacDonald Fredericks E, Kollins SH. A pilot study of methylphenidate preference assessment in children diagnosed with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2005;15:729–741.
   Google Scholar
• Brady JV, Lukas SE. Testing Drugs for Physical Dependence Potential and Abuse Liability. National Institute on Drug Abuse Monograph No. 52, Department of Health and Human Services Publication No. (ADM)90–1332. Washington, DC: US Government Printing Office; 1984.
   Google Scholar
• Brady JV, Hienz RD, Ator NA. Stimulus functions of drugs and the assessment of abuse liability. Drug Dev Res. 1990;20:231–249.
   Google Scholar
• Ward AS, Haney M, Fischman MW, Foltin RW. Binge cocaine self-administration in humans: intravenous cocaine. Psychopharmacology (Berl). 1997;132:375–381.
   PubMed Web of Science ®Google Scholar
• De Wit H, Johanson CE. A drug preference procedure for use with human volunteers. In: Bozarth MA, ed. Methods of Assessing the Reinforcing Properties of Abused Drugs. New York: Springer-Verlag; 1987:559–572.
   Google Scholar
• Nielsen JA, Duda NJ, Mokler DJ, Moore KE. Self-administration of central stimulants by rats: a comparison of the effects of d-amphetamine, methylphenidate and McNeil 4612. Pharmacol Biochem Behav. 1984;20:227–232.
   PubMed Web of Science ®Google Scholar
• Bergman J, Madras BK, Johnson SE, Spealman RD. Effects of cocaine and related drugs in nonhuman primates: III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther. 1989;251:150–155.
   PubMed Web of Science ®Google Scholar
• Rush CR, Essman WD, Simpson CA, Baker RW. Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans. J Clin Psychopharmacol. 2001;21:273–286.
   PubMed Web of Science ®Google Scholar
• Heil SH, Holmes HW, Bickel WK, , et al Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Depend. 2002;67:149–156.
   PubMed Web of Science ®Google Scholar
• Wee S, Woolverton WL. Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine. Drug Alcohol Depend. 2004;75:271–276.
   PubMed Web of Science ®Google Scholar
• Jasinski DR. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J Psychopharmacol. 2000;14:53–60.
   PubMed Web of Science ®Google Scholar
• Rush CR, Kelly TH, Hays LR, Baker RW, Wooten AF. Acute behavioral and physiological effects of modafinil in drug abusers. Behav Pharmacol. 2002;13:105–115.
   PubMed Web of Science ®Google Scholar
• Kollins SH, Rush CR, Pazzaglia PJ, Ali JA. Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate. Exp Clin Psychopharmacol. 1998;6:367–374.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Biederman J, Ciccone PE, , et al PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. Am J Psychiatry. 2006;163:387–395.
   PubMed Web of Science ®Google Scholar
• Fischman MW, Mello NK. Testing Drugs for Physical Dependence Potential and Abuse Liability. National Institute on Drug Abuse Monograph No. 52, Department of Health and Human Services Publication No. (ADM)90–1332. Washington, DC: US Government Printing Office; 1984.
   Google Scholar
• Lamb RJ, Griffiths RR. Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine. Psychopharmacology (Berl). 1990;102:183–190.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
   Google Scholar
• Weiner AL. Emerging drugs of abuse in Connecticut. Conn Med. 2000;64:19–23.
   PubMedGoogle Scholar
• Raskind M, Bradford T. Methylphenidate (Ritalin) abuse and methadone maintenance. Dis Nerv Syst. 1975;36:9–12.
   PubMedGoogle Scholar
• Crutchley A, Temlett JA. Methylphenidate (Ritalin) use and abuse. S Afr Med J. 1999;89:1076–1079.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Ding YS, Fowler JS, , et al Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry. 1995;52:456–463.
   PubMed Web of Science ®Google Scholar
• Musser CJ, Ahmann PA, Theye FW, Mundt P, Broste SK, Mueller-Rizner N. Stimulant use and the potential for abuse in Wisconsin as reported by school administrators and longitudinally followed children. J Dev Behav Pediatr. 1998;19:187–192.
   PubMed Web of Science ®Google Scholar
• McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use, and diversion of abusable prescription drugs. J Am Coll Health. 2006;54:269–278.
   PubMed Web of Science ®Google Scholar
• Teter CJ, McCabe SE, Cranford JA, Boyd CJ, Guthrie SK. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. J Am Coll Health. 2005;53:253–262.
   PubMed Web of Science ®Google Scholar
• McCabe SE, Teter CJ, Boyd CJ. The use, misuse and diversion of prescription stimulants among middle and high school students. Subst Use Misuse. 2004;39:1095–1116.
   PubMed Web of Science ®Google Scholar
• Kroutil LA, Van Brunt DL, Herman-Stahl MA, Heller DC, Bray RM, Penne MA. Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend. 2006;84(2):135–143.
   PubMed Web of Science ®Google Scholar